| # | Drug | Count |
|---|---|---|
| 0 | NATALIZUMAB | 9 |
| 1 | SODIUM CHLORIDE | 9 |
| 2 | SODIUM CHLORIDE TABLET | 9 |
| 3 | SODIUM CHLORIDE TABLETS | 9 |
| 4 | PREDNISONE | 8 |
| 5 | ACETAMINOPHEN | 7 |
| 6 | FERROUS SULFATE | 7 |
| 7 | IRON | 7 |
| 8 | VEDOLIZUMAB | 7 |
| 9 | ASPIRIN | 6 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | QUIZARTINIB | 1 | 0.0014 |
| 1 | MITAPIVAT | 1 | 0.0008 |
| 2 | HYALURONATE SODIUM | 1 | 0.0007 |
| 3 | ANTI-THYMOCYTE GLOBULIN (RABBIT) | 5 | 0.0006 |
| 4 | TRISODIUM CITRATE DIHYDRATE | 4 | 0.0006 |
| 5 | BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE CAPSULES | 1 | 0.0006 |
| 6 | FOSINOPRIL | 2 | 0.0005 |
| 7 | RESMETIROM | 1 | 0.0004 |
| 8 | PREDNISOLONE SODIUM PHOSPHATE | 1 | 0.0004 |
| 9 | ADALIMUMAB-AFZB | 1 | 0.0004 |
| # | Drug class | Count |
|---|---|---|
| 0 | Integrin Receptor Antagonist [EPC] | 16 |
| 1 | Corticosteroid [EPC] | 13 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 11 |
| 3 | Osmotic Laxative [EPC] | 10 |
| 4 | Tumor Necrosis Factor Blocker [EPC] | 8 |
| 5 | Platelet Aggregation Inhibitor [EPC] | 6 |
| 6 | Proton Pump Inhibitor [EPC] | 6 |
| 7 | Provitamin D2 Compound [EPC] | 6 |
| 8 | Vitamin C [EPC] | 6 |
| 9 | Estrogen [EPC] | 5 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Pyruvate Kinase Activator [EPC] | 1 | 0.0008 |
| 1 | Thyroid Hormone Receptor beta Agonist [EPC] | 1 | 0.0004 |
| 2 | Human C1 Esterase Inhibitor [EPC] | 1 | 0.0003 |
| 3 | Blood Viscosity Reducer [EPC] | 1 | 0.0002 |
| 4 | Ergot Derivative [EPC] | 1 | 0.0002 |
| 5 | Provitamin D2 Compound [EPC] | 6 | 0.0002 |
| 6 | Human Immunoglobulin G [EPC] | 4 | 0.0002 |
| 7 | Integrin Receptor Antagonist [EPC] | 16 | 0.0002 |
| 8 | Autologous Cellular Immunotherapy [EPC] | 1 | 0.0002 |
| 9 | Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] | 2 | 0.0001 |